Related Experiment Video
Updated: Jul 4, 2025

High-Resolution Endocardial and Epicardial Optical Mapping in a Sheep Model of Stretch-Induced Atrial Fibrillation
Published on: July 29, 2011
[Atrial fibrillation, an arrhythmia and a syndrome]
1División Enfermedades Cardiovasculares, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Insights
Atrial Fibrillation (AF) is a common heart rhythm disorder, especially in older adults, increasing stroke risk. Recent guidelines and new anticoagulant drugs offer improved safety and effectiveness for AF management.
Area of Science:
- Cardiology
- Geriatrics
- Pharmacology
Background:
- Atrial Fibrillation (AF) is the most common sustained cardiac arrhythmia, particularly prevalent in the elderly.
- AF significantly elevates the risk of ischemic stroke, heart failure, and mortality.
- Current diagnosis and treatment strategies for AF are under continuous evaluation and refinement.
Approach:
- This review examines recent European guidelines for Atrial Fibrillation management.
- It highlights advancements in treatment over the past decade, focusing on direct oral anticoagulants (DOACs).
- The analysis includes managing common comorbidities associated with AF.
Key Points:
- Direct oral anticoagulants demonstrate superior efficacy and safety compared to traditional vitamin K antagonists for AF treatment.
- Effective management of comorbidities like advanced age, heart failure, diabetes, and renal failure is crucial in AF patients.
- Emerging novel therapies for Atrial Fibrillation are anticipated in the near future.
Conclusions:
- Recent European guidelines and the advent of DOACs have significantly improved Atrial Fibrillation care.
- Comprehensive management addressing both AF and its comorbidities is essential for better patient outcomes.
- The evolving landscape of AF treatment promises further therapeutic advancements.
Abstract:
Atrial Fibrillation (AF) is the most common sustained arrhythmia and is highly prevalent in elderly patients. It confers a higher risk for ischemic stroke, heart failure and death. The diagnosis and treatment of AF has been extensively studied and remain under constant revision. This article reviews the recent European guidelines and the advances observed with the introduction of direct oral anticoagulants in the last ten years. This new family of drugs has clear benefits in terms of efficacy and safety compared with traditional vitamin K antagonists. Treatment of most common comorbidities in patients with AF such as advanced age, heart failure, diabetes, renal failure, and others are also analyzed. New therapies for AF will be shortly available.
More Related Videos
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
28:13Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Related Concept Videos
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Mechanism of Cardiac Arrhythmias
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Electrophysiology of Normal Cardiac Rhythm
The Cardiac Cycle
The Process
Electrical signals—sent from the sinoatrial (SA) node in the right atrial wall to the atrioventricular (AV) node between the right atrium and right ventricle—cause both atria to simultaneously contract. When the signal reaches the AV node, it pauses for approximately a tenth of a second, allowing the atria to contract and...